Alessandro Bucalossi
- Hematology top 5%
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Platelet Disorders and Treatments 2
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 2
-
- Lymphoma Diagnosis and Treatment 3
-
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Piero GalieniGiuseppe MarottaCatia BigazziFrancesco LauriaMonica BocchiaDomenico RussoS TuraMaria Teresa Petrucci
- Partner nations
- Italy
In The Last Decade
Alessandro Bucalossi
24 papers receiving 364 citations
Peers
Comparison fields: 5 of 47
- Hematology 218
- Genetics 160
- Pathology and Forensic Medicine 89
- Oncology 97
- Neurology 50
Countries citing papers authored by Alessandro Bucalossi
This map shows the geographic impact of Alessandro Bucalossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Bucalossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Bucalossi more than expected).
Fields of papers citing papers by Alessandro Bucalossi
This network shows the impact of papers produced by Alessandro Bucalossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Bucalossi. The network helps show where Alessandro Bucalossi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandro Bucalossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?] | 2022 | 0 |
| 4 | 2015 | 8 | |
| 5 | 2010 | 1 | |
| 6 | 2008 | 9 | |
| 7 | 2007 | 2 | |
| 8 | 2001 | 15 | |
| 9 | 2000 | 40 | |
| 10 | 1998 | 16 | |
| 11 | 1998 | 6 | |
| 12 | Localized orbital lymphoma. | 1997 | 49 |
| 13 | 1996 | 54 | |
| 14 | Variant t(1;15;17)(q23;q22;q23) in a case of acute promyelocytic leukemia. | 1996 | 11 |
| 15 | ALPHA-INTERFERON IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: CLINICAL RESULTS AND EVALUATION OF ITS BIOLOGICAL EFFECTS ON THE HEMATOPOIETIC NEOPLASTIC CLONE. | 1996 | 1 |
| 16 | 1996 | 2 | |
| 17 | 1995 | 67 | |
| 18 | 1994 | 33 | |
| 19 | 1994 | 14 | |
| 20 | 1993 | 22 |
About Alessandro Bucalossi
Alessandro Bucalossi is a scholar working on Hematology, Genetics, Transplantation, Immunology and Infectious Diseases, having authored 26 papers that have together received 379 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Hematology (218 citations), Genetics (160 citations), Pathology and Forensic Medicine (89 citations), Oncology (97 citations) and Neurology (50 citations). Alessandro Bucalossi has collaborated with scholars based in Italy. Frequent co-authors include Piero Galieni, Giuseppe Marotta, Catia Bigazzi, Francesco Lauria, Monica Bocchia, Domenico Russo, S Tura, Maria Teresa Petrucci, Michèle Cavo and Alessandro Pulsoni. Their work appears in journals such as Acta Haematologica, Acta Neuropathologica, Leukemia, Journal of Clinical Microbiology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.